INFLUENZA

This study is testing a new version of the seasonal flu vaccine to see how well it triggers an immune response and how safe it is for people aged 60 and above. It will involve 1,200 participants who will receive either the new vaccine or a currently available one for comparison. …

This study is testing an experimental flu vaccine called BPL-1357 to see if it is safe and can protect people from getting sick with the flu. Healthy adults aged 18-55 will receive the vaccine either as a shot in the arm, a spray in the nose, or a placebo. Later, some participant…

This is an early-stage study to check if a new flu vaccine, which includes a special ingredient called BK-01 adjuvant, is safe and can trigger a good immune response in healthy adults. Researchers will give the vaccine to 160 people and closely monitor them for any side effects f…

This early-stage study is testing a new experimental flu vaccine called H1ssF, which researchers hope could provide broader protection against multiple flu strains. The trial will compare this new vaccine to the current seasonal flu shot (Flucelvax) in 112 adults, including some …

This study aims to find out if adding steroid medication to standard care can help adults with severe flu pneumonia survive. It will test different steroid doses in nearly 500 critically ill patients in intensive care units. The goal is to see if steroids reduce deaths within 28 …

This study is testing if a new pill called Onradivir can help teenagers with the flu get better faster. About 150 teens aged 12-17 with confirmed flu A will take either the real pill or a placebo for 5 days. Researchers will track how quickly their symptoms go away and how much f…

This study aims to prevent flu from spreading between patients sharing a hospital room. Researchers will test if taking antiviral drugs (suraxavir marboxil or oseltamivir) can protect uninfected roommates from catching the flu from their roommate who has it. The study will enroll…

This is a follow-up study to see if a dietary supplement called TUDCA, taken during a flu shot, helps the vaccine's protection last longer in adults aged 60-70. Researchers will check blood samples from 30 people about 8 months after their vaccination to measure remaining antibod…

This study aims to understand how the brain changes in people who have lost or have a distorted sense of smell, often after illnesses like COVID-19 or the flu. Researchers will follow 80 adults with smell disorders and healthy volunteers for one year, using brain scans, smell tes…